MannKind (MNKD) News Today $3.52 +0.09 (+2.62%) Closing price 04:00 PM EasternExtended Trading$3.58 +0.06 (+1.56%) As of 05:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MNKD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Royal Bank Of Canada Has Lowered Expectations for MannKind (NASDAQ:MNKD) Stock Price5 hours ago | marketbeat.comMannKind (NASDAQ:MNKD) Sets New 52-Week Low - Here's What HappenedAugust 7 at 12:28 PM | marketbeat.comMannKind Corporation (NASDAQ:MNKD) Q2 2025 Earnings Call TranscriptAugust 7 at 9:22 AM | insidermonkey.comMannKind outlines $500M Blackstone financing while advancing Afrezza pediatric launch and IPF pipelineAugust 7 at 3:38 AM | msn.comMannKind Corporation Reports Q2 2025 Financial GrowthAugust 6 at 12:39 AM | tipranks.comDecoding MannKind Corp (MNKD): A Strategic SWOT InsightAugust 6 at 12:39 AM | gurufocus.comQ2 2025 MannKind Corp Earnings Call TranscriptAugust 6 at 12:15 AM | gurufocus.comMannKind Corporation (MNKD) Q2 2025 Earnings Conference Call TranscriptAugust 6 at 6:13 PM | seekingalpha.comMannKind Corporation: A Post-Q2 AssessmentAugust 6 at 5:36 PM | seekingalpha.comMannKind Corporation: A Post-Q2 AssessmentAugust 6 at 5:06 PM | seekingalpha.comPromising Outlook for MannKind: Buy Rating Justified by Clinical Progress and Financial StrengthAugust 6 at 1:31 PM | tipranks.comMannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business UpdateAugust 6 at 10:02 AM | gurufocus.comMannKind (MNKD) Shares Dip on Revenue Miss and Declining DemandAugust 6 at 10:01 AM | gurufocus.comMannKind stock falls after profit and revenue missAugust 6 at 9:32 AM | seekingalpha.comMannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business UpdateAugust 6 at 7:17 AM | globenewswire.comMannKind and Blackstone Announce up to $500 Million Strategic Financing AgreementAugust 6 at 7:10 AM | globenewswire.comMannKind (MNKD) Prepares to Announce Q2 EarningsAugust 5 at 1:43 PM | gurufocus.comMannKind Q2 2025 Earnings PreviewAugust 5 at 12:42 PM | seekingalpha.comMannKind (NASDAQ:MNKD) Lowered to Hold Rating by Wall Street ZenAugust 3, 2025 | marketbeat.comFederated Hermes Inc. Cuts Stock Position in MannKind Corporation (NASDAQ:MNKD)August 3, 2025 | marketbeat.comH.C. Wainwright Affirms MannKind Corp (MNKD)’s ‘Buy’ Rating Buoyed by Product PipelineAugust 1, 2025 | insidermonkey.comWedbush Remains Bullish on MannKind Corporation (MNKD)August 1, 2025 | msn.comMannKind (MNKD) Expected to Announce Quarterly Earnings on WednesdayJuly 31, 2025 | marketbeat.comMannKind Corporation to Release Second Quarter 2025 Financial Results and Host Webcast on August 6, 2025July 30, 2025 | quiverquant.comQMannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025July 30, 2025 | globenewswire.comVictory Capital Management Inc. Acquires 137,833 Shares of MannKind Corporation (NASDAQ:MNKD)July 30, 2025 | marketbeat.comRBC Capital Lowered the PT on MannKind Corporation (MNKD), Kept a Buy RatingJuly 28, 2025 | insidermonkey.comMannKind Corporation (MNKD) Presented Inhaled Insulin Therapy At American Diabetes AssociationJuly 23, 2025 | insidermonkey.comMannKind (NASDAQ:MNKD) Given New $8.00 Price Target at Royal Bank Of CanadaJuly 23, 2025 | marketbeat.comHC Wainwright Estimates MannKind FY2025 EarningsJuly 21, 2025 | marketbeat.comMannKind Corporation (NASDAQ:MNKD) Receives Average Rating of "Buy" from AnalystsJuly 19, 2025 | marketbeat.comMannKind (NASDAQ:MNKD) Upgraded at Wall Street ZenJuly 19, 2025 | marketbeat.comMannKind Corporation (NASDAQ:MNKD) Director Steven B. Binder Sells 75,367 SharesJuly 18, 2025 | marketbeat.comInsider Selling: MannKind Corporation (NASDAQ:MNKD) Director Sells 75,367 Shares of StockJuly 18, 2025 | insidertrades.comHC Wainwright Estimates MannKind's Q2 Earnings (NASDAQ:MNKD)July 18, 2025 | marketbeat.comMannKind's (MNKD) Buy Rating Reiterated at HC WainwrightJuly 16, 2025 | marketbeat.comWells Fargo Maintains a Buy Rating on MannKind Corporation (MNKD), Sets a $9 PTJuly 11, 2025 | insidermonkey.comMannKind (NASDAQ:MNKD) Hits New 52-Week Low - Here's WhyJuly 7, 2025 | marketbeat.comMannKind (NASDAQ:MNKD) Hits New 1-Year Low - What's Next?July 1, 2025 | marketbeat.comMannKind (NASDAQ:MNKD) Rating Lowered to "Hold" at Wall Street ZenJune 27, 2025 | marketbeat.comHealth Rounds: Inhaled insulin as good as injection for children at mealtimeJune 25, 2025 | reuters.comMannKind (NASDAQ:MNKD) Stock Price Down 5.6% - What's Next?June 25, 2025 | marketbeat.comLeerink Partners Slashes MannKind Corporation’s (MNKD) Price Target to $7, Keeps a Buy RatingJune 24, 2025 | insidermonkey.comMannKind Corporation (NASDAQ:MNKD) Given Average Recommendation of "Buy" by BrokeragesJune 24, 2025 | marketbeat.comMannKind FY2026 EPS Forecast Decreased by Leerink PartnrsJune 19, 2025 | marketbeat.comMannKind (NASDAQ:MNKD) Reaches New 1-Year Low - Should You Sell?June 17, 2025 | marketbeat.comMannKind’s Afrezza: A Significantly Undervalued Investment Opportunity with Promising Clinical DataJune 16, 2025 | tipranks.comMannKind (NASDAQ:MNKD) Upgraded by Wall Street Zen to "Buy" RatingJune 14, 2025 | marketbeat.comInsider Selling: MannKind Co. (NASDAQ:MNKD) Director Sells 64,085 Shares of StockJune 11, 2025 | insidertrades.comInsider Sell: Steven Binder Sells 64,085 Shares of MannKind Corp (MNKD)June 10, 2025 | gurufocus.com Get MannKind News Delivered to You Automatically Sign up to receive the latest news and ratings for MNKD and its competitors with MarketBeat's FREE daily newsletter. Email Address MNKD Media Mentions By Week MNKD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MNKD News Sentiment▼0.410.38▲Average Medical News Sentiment MNKD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MNKD Articles This Week▼235▲MNKD Articles Average Week Get MannKind News Delivered to You Automatically Sign up to receive the latest news and ratings for MNKD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alkermes News Ligand Pharmaceuticals News Amicus Therapeutics News BioCryst Pharmaceuticals News Celldex Therapeutics News Dynavax Technologies News Innoviva News Novavax News OPKO Health News Geron News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MNKD) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MannKind Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share MannKind With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MNKD Stock Alerts